Envue Medical Inc (FEED) Stock Price, Quote & News

Company Profile

ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The c...

Industry: Medical Devices

Sector: Healthcare

Phone: (914) 233-3004

Website: envuemed.com

Address:

969 Pruitt Ave, Tyler, United States

lavegow902 Feb. 4 at 5:17 PM

$FEED ,

0 · Reply

Simple_Math Feb. 4 at 5:15 PM

$FEED, needs to break 3 and 3.20 for a run back up, this stock can move quietly and been following it for a few weeks now. lets get back to 5$ , 4$ is a realistic price target today. lets go

0 · Reply

IIStock_LesnarII Feb. 4 at 5:15 PM

$BOXL $FEED $MOBX $TIRX $ZCMD MOBX — Holding well— reversal incoming

0 · Reply

_BUBBLES_ Feb. 4 at 5:11 PM

$FEED The market has been BLEEDING for 3 days.. and this big beautiful bitch has been trucking along just fine.. this will see $5+ before it sees sub $2

0 · Reply

IIStock_LesnarII Feb. 4 at 5:09 PM

$MOBX $FEED $TIRX $ZCMD $BOXL MOBX — Love taps Support holding well Great news for the company today https://finance.yahoo.com/news/mobix-labs-launches-field-deployment-141700637.html

0 · Reply

wolfden2000 Feb. 4 at 5:03 PM

$FEED congrats if u loaded under $2.7

0 · Reply

ForTheBigGuy1 Feb. 4 at 5:01 PM

$BOXL $ELPW $FEED $MOBX $ZCMD

0 · Reply

nerowinger Feb. 4 at 5:01 PM

$FEED sold. Dilution for sure kill all this runs….

0 · Reply

SqueezeGod Feb. 4 at 4:59 PM

$FEED doubled down at $2.75. Now own 1% of the company. Will add more if dip persists

0 · Reply

_BUBBLES_ Feb. 4 at 4:57 PM

$FEED Well.. I suppose this will just go to zero now😂😂 it must be some of y’all’s first day lmao BULLISH

0 · Reply

EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal

Jan 21, 2026, 8:30 AM EST - 14 days ago

ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial

Jan 9, 2026, 9:01 AM EST - 26 days ago

ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research

Dec 18, 2025, 12:30 PM EST - 6 weeks ago

ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK

Dec 15, 2025, 9:00 AM EST - 7 weeks ago

ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

Dec 12, 2025, 8:00 AM EST - 7 weeks ago

NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED'

Nov 19, 2025, 8:00 AM EST - 2 months ago

NanoVibronix Issues Letter to Shareholders

Sep 18, 2025, 8:00 AM EDT - 4 months ago

NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities

Sep 16, 2025, 3:57 PM EDT - 5 months ago

NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 15, 2025, 8:00 AM EDT - 5 months ago

NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio

Sep 4, 2025, 8:00 AM EDT - 5 months ago

NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology

Aug 8, 2025, 9:00 AM EDT - 6 months ago

NanoVibronix Announces Reverse Stock Split

Jul 18, 2025, 9:00 AM EDT - 7 months ago

NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock

Jun 26, 2025, 8:00 AM EDT - 7 months ago

NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation

Jun 24, 2025, 8:00 AM EDT - 8 months ago

NanoVibronix's ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement

Jun 11, 2025, 8:00 AM EDT - 8 months ago

ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System

Jun 4, 2025, 8:38 AM EDT - 8 months ago

NanoVibronix Announces CEO Transition

May 28, 2025, 4:22 PM EDT - 8 months ago

NanoVibronix Responds to False Post

May 28, 2025, 8:00 AM EDT - 9 months ago

Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures

May 16, 2025, 4:30 PM EDT - 9 months ago

NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants

May 15, 2025, 9:00 AM EDT - 9 months ago

NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants

May 12, 2025, 8:50 AM EDT - 9 months ago

NanoVibronix Announces Results from UroShield™ Case Series

Apr 11, 2025, 8:00 AM EDT - 10 months ago

NanoVibronix Regains Nasdaq Compliance

Apr 1, 2025, 8:00 AM EDT - 11 months ago

NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia

Mar 14, 2025, 8:00 AM EDT - 11 months ago

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal

Feb 14, 2025, 9:43 AM EST - 1 year ago

NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.

Jan 7, 2025, 8:00 AM EST - 1 year ago

NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes

Jan 6, 2025, 8:00 AM EST - 1 year ago

NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan

Dec 11, 2024, 8:00 AM EST - 1 year ago

NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement

Nov 12, 2024, 8:00 AM EST - 1 year ago

NanoVibronix Provides Business Update

Oct 9, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany

Sep 23, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Signs Letter of Intent with Potential New Distributor

Aug 21, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders

May 22, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan

May 16, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Issues Letter to Stockholders

May 14, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

May 1, 2024, 8:00 AM EDT - 1 year ago

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award

Apr 24, 2024, 1:00 PM EDT - 1 year ago

NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024

Mar 28, 2024, 8:30 AM EDT - 2 years ago

NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield

Dec 6, 2023, 9:00 AM EST - 2 years ago

NanoVibronix Featured in Your Bladder Health Magazine

Dec 4, 2023, 9:00 AM EST - 2 years ago

NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity

Nov 28, 2023, 9:00 AM EST - 2 years ago

NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan

Nov 7, 2023, 8:30 AM EST - 2 years ago

NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1

Sep 27, 2023, 8:00 AM EDT - 2 years ago

NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

Sep 6, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting

Aug 30, 2023, 2:29 PM EDT - 2 years ago

NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Aug 30, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Cites Positive Results from Independent Testing of UroShield

Aug 29, 2023, 4:05 PM EDT - 2 years ago

NanoVibronix Responds to CMS' Determination for PainShield

Aug 28, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

Aug 23, 2023, 8:45 AM EDT - 2 years ago

NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus

lavegow902 Feb. 4 at 5:17 PM

$FEED ,

0 · Reply

Simple_Math Feb. 4 at 5:15 PM

$FEED, needs to break 3 and 3.20 for a run back up, this stock can move quietly and been following it for a few weeks now. lets get back to 5$ , 4$ is a realistic price target today. lets go

0 · Reply

IIStock_LesnarII Feb. 4 at 5:15 PM

$BOXL $FEED $MOBX $TIRX $ZCMD MOBX — Holding well— reversal incoming

0 · Reply

_BUBBLES_ Feb. 4 at 5:11 PM

$FEED The market has been BLEEDING for 3 days.. and this big beautiful bitch has been trucking along just fine.. this will see $5+ before it sees sub $2

0 · Reply

IIStock_LesnarII Feb. 4 at 5:09 PM

$MOBX $FEED $TIRX $ZCMD $BOXL MOBX — Love taps Support holding well Great news for the company today https://finance.yahoo.com/news/mobix-labs-launches-field-deployment-141700637.html

0 · Reply

wolfden2000 Feb. 4 at 5:03 PM

$FEED congrats if u loaded under $2.7

0 · Reply

ForTheBigGuy1 Feb. 4 at 5:01 PM

$BOXL $ELPW $FEED $MOBX $ZCMD

0 · Reply

nerowinger Feb. 4 at 5:01 PM

$FEED sold. Dilution for sure kill all this runs….

0 · Reply

SqueezeGod Feb. 4 at 4:59 PM

$FEED doubled down at $2.75. Now own 1% of the company. Will add more if dip persists

0 · Reply

_BUBBLES_ Feb. 4 at 4:57 PM

$FEED Well.. I suppose this will just go to zero now😂😂 it must be some of y’all’s first day lmao BULLISH

0 · Reply

IIStock_LesnarII Feb. 4 at 4:56 PM

$MOBX $ELPW $BOXL $FEED $ZCMD MOBX — Company news today Shorts are stuck & over extended News : https://finance.yahoo.com/news/mobix-labs-launches-field-deployment-141700637.html

0 · Reply

wolfden2000 Feb. 4 at 4:55 PM

$FEED gap filled. This is area to load imo

0 · Reply

Alternative1 Feb. 4 at 4:50 PM

$FEED Bagholders never listen. This garbage company can dilute till it goes to $0 since they filed the amendment last Friday. Occasionally, they will pump only to dump at higher prices. That's all. RED incoming

1 · Reply

pooch0 Feb. 4 at 4:46 PM

$FEED yikes

0 · Reply

victory369 Feb. 4 at 4:46 PM

$FEED Here we go guys 😁

0 · Reply

LBTheEmcee Feb. 4 at 4:45 PM

$FEED can’t make it up

0 · Reply

Alternative1 Feb. 4 at 4:45 PM

$FEED RED incoming

0 · Reply

LBTheEmcee Feb. 4 at 4:43 PM

$FEED cooked

0 · Reply

_SqueezeChamber Feb. 4 at 4:38 PM

If you’ve ever wanted to catch a short squeeze early instead of watching it rip after the fact, this group is built for that. Sharing momentum, setups, and what we’re watching as it develops, not when it’s already gone. Click link and join for Free ⭐ $SIDU $CAN $QBTS $FEED *

1 · Reply

StockSenseiTrendTraders Feb. 4 at 4:38 PM

🔥 Top Winning Alerts Today! 🔥 1️⃣ $BOXL 🚀 +45.4% 🔹 Entry Alerts: 1.63 & 1.78 🔹 Ran To: 2.37 2️⃣ $FEED 🚀 +16.40% 🔹 Entry Alert: 3.17 🔹 Ran To: 3.69 3️⃣ $CIGL 🚀 +13.08% 🔹 Entry Alert: 4.28 🔹 Ran To: 4.84 📊 2026 Performance Highlights ✅ Wins: 98 ❌ Losses: 14 🚀 Gain Potential: +4,140% ✨ Avg Gain/Winning Alert: 42.24% 💡 Another disciplined day of execution. No need to force trades—clean entries, smart exits, and consistency keep the edge sharp.

0 · Reply

EagleFury Feb. 4 at 4:33 PM

Join Starlight ⬇️ ~One of the strongest small-cap communities out there. No fees/ No fluff. Just real value. Limited spots available, don’t miss out... $RKLZ $PLTZ $FEED << did great today!!

0 · Reply

MadMaverick Feb. 4 at 4:29 PM

Watchlist trades ✅ $MOBX smashed all targets ✅ $FEED smashed all targets ✅ $ELPW smashed all targets ✅ $BOXL smashed all targets 4/4 💰

0 · Reply

Market Cap	3.52M
Revenue (ttm)	2.56M
Net Income (ttm)	-3.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-144.92%
Debt to Equity Ratio	0.02

Volume	2,757,900
Avg Vol	10,903,361
Day's Range	N/A - N/A
Shares Out	1.09M
Stochastic %K	29%
Beta	2.09
Analysts	Strong Buy
Price Target	$3.50